Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies ; volume:40 ; number:1 ; day:18 ; month:11 ; year:2021 ; pages:1-23 ; date:12.2021
Journal of experimental & clinical cancer research ; 40, Heft 1 (18.11.2021), 1-23, 12.2021
- Creator
-
Xiao, Xinyi
Huang, Shengkang
Chen, Sifei
Wang, Yazhuo
Sun, Qihang
Xu, Xinjie
Li, Yuhua
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-021-02148-6
- URN
-
urn:nbn:de:101:1-2022012818160881233310
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Xiao, Xinyi
- Huang, Shengkang
- Chen, Sifei
- Wang, Yazhuo
- Sun, Qihang
- Xu, Xinjie
- Li, Yuhua
- SpringerLink (Online service)
Other Objects (12)
Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy
Steroid hormones and the T-cell cytokine profile
Description of neurotoxicity in a series of patients treated with CAR T-cell therapy
EEG features and synek scale indicate severity of neurotoxicity in adult patients treated with CD19 CAR T-cell therapy
CAR T-Cell therapy
Dynamics of the IL-2 cytokine network and T-cell proliferation
Neurological management and work-up of neurotoxicity associated with CAR T cell therapy
T-cell signaling of macrophage activation: cell contact dependent and cytokine signals
An in vitro model of the macrophage-endothelial interface to characterize CAR T-cell induced cytokine storm
Methamphetamine neurotoxicity, microglia, and neuroinflammation
Deciphering and advancing CAR T-cell therapy with single-cell sequencing technologies
The Retinoic Acid Receptor-α mediates human T-cell activation and Th2 cytokine and chemokine production
Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy
Steroid hormones and the T-cell cytokine profile
Description of neurotoxicity in a series of patients treated with CAR T-cell therapy
EEG features and synek scale indicate severity of neurotoxicity in adult patients treated with CD19 CAR T-cell therapy
CAR T-Cell therapy
Dynamics of the IL-2 cytokine network and T-cell proliferation
Neurological management and work-up of neurotoxicity associated with CAR T cell therapy
T-cell signaling of macrophage activation: cell contact dependent and cytokine signals
An in vitro model of the macrophage-endothelial interface to characterize CAR T-cell induced cytokine storm
Methamphetamine neurotoxicity, microglia, and neuroinflammation
Deciphering and advancing CAR T-cell therapy with single-cell sequencing technologies
The Retinoic Acid Receptor-α mediates human T-cell activation and Th2 cytokine and chemokine production
Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy
Steroid hormones and the T-cell cytokine profile
Description of neurotoxicity in a series of patients treated with CAR T-cell therapy
EEG features and synek scale indicate severity of neurotoxicity in adult patients treated with CD19 CAR T-cell therapy
CAR T-Cell therapy
Dynamics of the IL-2 cytokine network and T-cell proliferation
Neurological management and work-up of neurotoxicity associated with CAR T cell therapy
T-cell signaling of macrophage activation: cell contact dependent and cytokine signals
An in vitro model of the macrophage-endothelial interface to characterize CAR T-cell induced cytokine storm
Methamphetamine neurotoxicity, microglia, and neuroinflammation
Deciphering and advancing CAR T-cell therapy with single-cell sequencing technologies